Curative Biosciences, Inc.
CBDX
$0.00
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | -32.00K | -451.50K | -16.70K | -17.90K | -4.00K |
| Total Depreciation and Amortization | 500.00 | 700.00 | 700.00 | 700.00 | 700.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 425.30K | -- | 16.50K | 0.00 |
| Change in Net Operating Assets | 0.00 | -5.50K | -1.70K | -1.00K | 1.30K |
| Cash from Operations | -31.50K | -31.00K | -17.60K | -1.70K | -2.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.50K | -- | -- | -- | -- |
| Cash from Investing | -12.50K | -- | -- | -- | -- |
| Total Debt Issued | 45.00K | 31.00K | 17.60K | 1.70K | 2.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.00K | 31.00K | 17.60K | 1.70K | 2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00K | -- | -- | -- | -- |